Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunomodulatory Drugs”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Not applicableStudy completedNCT06160167
What this trial is testing

Incidence of Hyperpigmentation in Black Patients With Multiple Myeloma Treated With Immunomodulatory Drugs

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 4,204
Post-approval studies (Phase 4)Study completedNCT00735072
What this trial is testing

Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure

Who this might be right for
HIV Infection
University of California, San Francisco 45
Testing effectiveness (Phase 2)Looking for participantsNCT06941376
What this trial is testing

An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis

Who this might be right for
Relapsing Polychondritis
University of Pennsylvania 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04649359
What this trial is testing

MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb

Who this might be right for
Multiple Myeloma
Pfizer 187
Early research (Phase 1)Study completedNCT01088048
What this trial is testing

Study to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Participants With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
Indolent Non-Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma
Gilead Sciences 241
Early research (Phase 1)Study completedNCT03269136
What this trial is testing

PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Pfizer 101
Testing effectiveness (Phase 2)UnknownNCT04309981
What this trial is testing

Clinical Trial Using Humanized CART Directed Against BCMA (ARI0002h) in Patients With Relapsed/Refractory Multiple Myeloma to Proteasome Inhibitors, Immunomodulators and Anti-CD38 Antibody.

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Sara V. Latorre 73
Testing effectiveness (Phase 2)Study completedNCT03944057
What this trial is testing

Evaluating the Safety and Efficacy of ATG-010 in Relapsed Refractory Multiple Myeloma

Who this might be right for
Relapse/Refractory Multiple Myeloma
Antengene Corporation 82
Testing effectiveness (Phase 2)Ended earlyNCT01675141
What this trial is testing

Lenalidomide Maintenance Therapy for Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 11
Not applicableUnknownNCT04769258
What this trial is testing

Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD)

Who this might be right for
Inflammatory Bowel Diseases
Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) 1,380
Not applicableStudy completedNCT06054438
What this trial is testing

Examining the Function of Cs4 on Post-COVID-19 Disorders

Who this might be right for
Long COVID
The University of Hong Kong 110
Not applicableStudy completedNCT03530215
What this trial is testing

Evaluation of Reporting of Cardio-vascular Adverse Events With Antineoplastic and Immunomodulating Agents (EROCA)

Who this might be right for
Cardiac DiseaseCancer
Groupe Hospitalier Pitie-Salpetriere 500,000
Early research (Phase 1)Study completedNCT00101374
What this trial is testing

Effect of Leflunomide on T Cell Proliferation in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 41
Testing effectiveness (Phase 2)Study completedNCT03525678
What this trial is testing

Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 221
Testing effectiveness (Phase 2)Study completedNCT01985126
What this trial is testing

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 124
Early research (Phase 1)Study completedNCT04447027
What this trial is testing

Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies

Who this might be right for
Cutaneous T-Cell LymphomaMature T-cell MalignanciesPeripheral T-Cell Lymphoma+1 more
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Ended earlyNCT02757326
What this trial is testing

ABC294640 (Opaganib) in Refractory / Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma
RedHill Biopharma Limited 13
Testing effectiveness (Phase 2)Study completedNCT00091260
What this trial is testing

CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma
Vaishali Sanchorawala 82
Not applicableLooking for participantsNCT07033663
What this trial is testing

Impact of In Utero Exposure to Immunomodulatory Drugs on Neonatal Immune System Development

Who this might be right for
Pregnancy RelatedImmune-mediated Diseases
Fundació Sant Joan de Déu 90
Testing effectiveness (Phase 2)Ended earlyNCT01545518
What this trial is testing

IVIG Treatment for Refractory Immune-Related Adult Epilepsy

Who this might be right for
Epilepsy, CryptogenicEpilepsy, PartialSeizure Disorder+2 more
Emory University 20
Load More Results